Olatunji B. Alese

Olatunji B. Alese, MD, is an Associate Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. He serves as Director of Gastrointestinal Oncology at Winship Cancer Institute of Emory University and specializes in

• Colorectal Cancer
• Neuroendocrine Tumors
• Pancreatic Cancer

His clinical practice since 2015 focuses on gastrointestinal malignancies, with leadership roles in clinical trial design and translational research.

Education:

• MD from University of Ibadan (Nigeria)
• Residency at University College Hospital, Nigeria
• Residency in Internal Medicine at New York Medical College
• Fellowship in Hematology/Oncology at Emory University

Dr. Alese's research explores colorectal cancer and health disparities, particularly examining tumor biology, immune microenvironment interactions, and treatment outcomes across diverse populations. Current studies include:

• Immunotherapy combinations (e.g., XL888 + pembrolizumab)
• Role of transposon sequences in tumor DNA transfer
• Genetic polymorphisms affecting chemotherapy response
• Technology-based interventions for patient-caregiver dyads

His 15 most recent publications span clinical trials in immunotherapy, pharmacokinetic studies, and health disparities research, with recurring themes in

• Gastrointestinal Cancers
• Immuno-Oncology
• Pharmacogenomics
• Digital Health Interventions

Scientific Awards:

• ASCO International Development and Education Award
• ECOG Foundation Fellowship
• UICC International Cancer Technology Transfer Fellow
• ASCO Merit Award
• German Academic Exchange Service (DAAD) Scholar